TIBRENGA Trademark

Trademark Overview


On Tuesday, June 30, 2020, a trademark application was filed for TIBRENGA with the United States Patent and Trademark Office. The USPTO has given the TIBRENGA trademark a serial number of 79291285. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, March 21, 2024. This trademark is owned by NOVARTIS AG. The TIBRENGA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the pr...
tibrenga

General Information


Serial Number79291285
Word MarkTIBRENGA
Filing DateTuesday, June 30, 2020
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, March 21, 2024
Registration Number6224683
Registration DateTuesday, December 22, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 6, 2020

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, March 21, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Monday, August 17, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, August 6, 2020SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Tuesday, August 18, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 25, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 25, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 25, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, August 22, 2020APPLICATION FILING RECEIPT MAILED
Tuesday, August 25, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 25, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 25, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, September 1, 2020ASSIGNED TO EXAMINER
Wednesday, September 2, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 16, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 6, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Saturday, October 24, 2020NOTIFICATION PROCESSED BY IB
Wednesday, September 30, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 30, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, October 6, 2020PUBLISHED FOR OPPOSITION
Tuesday, December 22, 2020REGISTERED-PRINCIPAL REGISTER
Saturday, February 6, 2021FINAL DISPOSITION NOTICE SENT TO IB
Thursday, January 21, 2021GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Friday, February 5, 2021FINAL DISPOSITION PROCESSED
Sunday, February 28, 2021NOTIFICATION PROCESSED BY IB
Wednesday, October 16, 2024DEATH OF INTERNATIONAL REGISTRATION
Wednesday, October 16, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED